Ensysce Biosciences (ENSCW) Operating Expenses (2018 - 2025)

Ensysce Biosciences (ENSCW) has 8 years of Operating Expenses data on file, last reported at $4.2 million in Q3 2025.

• Operating Expenses for Q3 2025 came in at $4.2 million, up 52.63% year-over-year; the trailing twelve-month figure through Dec 2025 was $10.6 million (down 10.86% YoY), and the FY2024 annual result was $11.9 million, down 7.79% from the prior year.
• Operating Expenses climbed to $4.2 million in Q3 2025 per ENSCW's latest filing, from $3.1 million in the prior quarter.
• Over five years, Operating Expenses peaked at $18.1 million in Q3 2021 and troughed at $774849.0 in Q1 2021.
• A 5-year average of $4.5 million and a median of $3.4 million in 2023 frame the typical range for Operating Expenses.
• The sharpest annual moves came in 2021 and 2022: Operating Expenses surged 1367.66% in 2021, then plunged 64.38% in 2022.
• A 5-year view of Operating Expenses shows it stood at $3.6 million in 2021, then surged by 109.61% to $7.6 million in 2022, then tumbled by 51.92% to $3.7 million in 2023, then soared by 32.95% to $4.9 million in 2024, then declined by 13.24% to $4.2 million in 2025.
• Business Quant data shows ENSCW's Operating Expenses at $4.2 million in Q3 2025, $3.1 million in Q2 2025, and $3.3 million in Q1 2025.